U.S. Paper and Forestry Products Stock News

How Levi Strauss Stock Has Been Performing Levi Strauss (LEVI) has been on the radar for investors watching apparel stocks, with the share price at $24.41 as of the last close. Recent performance metrics across different time frames help frame how the stock has been trading. Over the past day, the stock moved 0.45%. Over the past week it declined 0.45%. Over the past month it returned 0.16%, while over the past 3 months it returned 7.68%. Looking at longer horizons, Levi Strauss shows a year...

Allstate shareholders woke up to a reality check. The stock slipped almost 3% to about US$267 even though the insurer just printed another quarter of heavy profits and tight underwriting. Q2 adjusted earnings landed at US$8.99 per share, with net income of US$3.2b and a Property and Casualty combined ratio of 86.6%, which points to solid profitability for an insurer. The stock has run hard over the past three months and then cooled on the day, right as Allstate posted strong income and...

The latest U.S. jobs report showed a loss of 23,000 positions in July and weaker participation, which has put income and job security back at the center of every portfolio conversation. With wage growth still lagging inflation and rate expectations shifting, many investors are rethinking where to seek steadier cash flows. This article looks at three dividend stocks exposed to this news and how their income profiles might matter for you now. The stocks in the list below are just a starting...

Why SecureFuel Matters For WEX Stock WEX (WEX) has launched SecureFuel for North American fleet customers, using AI, fleet card data, and real-time vehicle information to flag potentially unauthorized fuel purchases before approval within its existing WEXOnline platform. See our latest analysis for WEX. WEX shares closed at $185.22, with the stock down 2.28% on a 1 day share price return basis. The shares are showing stronger momentum with a 30 day share price return of 24.56% and a 1 year...

What the Raytheon SM-3 contract means for Voyager Technologies stock Voyager Technologies (VOYG) has drawn fresh attention after Raytheon, an RTX business, awarded the company a contract to supply propulsion and divert, attitude and control systems for the Standard Missile 3 interceptor family. This contract highlights Voyager Technologies’ role in solid propulsion and precision maneuvering systems for missiles and space payloads, which already sit at the core of its Defense & National...

Check Point Software Technologies (CHKP) drew investor attention after reporting second quarter 2026 results, issuing third quarter revenue guidance, launching its AI Network Firewall, and updating progress on a long running share repurchase plan. See our latest analysis for Check Point Software Technologies. The recent 1-day share price return of 2.03% and 7-day share price return of 0.54% suggest a short-term rebound after a 30-day share price return that declined 6.60%. However, the 1-year...

Southern has delivered a 68.4% total return over the past five years, yet its low overall value score and current checks suggest the stock does not screen as an obvious bargain at around US$92.69. A 68.4% return over five years puts Southern in solid long term territory. This can reduce the margin of safety if earnings and cash flow do not keep up with the share price over time. New large load contracts, such as the 3.2 GW OpenAI agreement, and sizable convertible note issuance can support...

China’s trade surplus is widening, helped by AI related exports even as tariff frictions linger. That highlights how powerful the ChatGPT and AI wave has become for companies supplying chips, software, cloud and large language models. Investors who ignore this theme risk missing some of the most discussed growth stories of this cycle. This article walks through 3 AI stocks from the screener that many investors are watching closely. The 3 stocks below are just a sample, and the full screen...

Helios Technologies (HLIO) is in focus after Wall Street analysts issued fresh projections for its upcoming quarter, including an earnings per share estimate of $0.80 and revenue expectations implying 8.4% year over year growth. See our latest analysis for Helios Technologies. Against this backdrop of higher earnings expectations, Helios Technologies’ share price of $82.32 follows a 7 day share price return of 5.93% and a 90 day share price return of 20.67%. The 1 year total shareholder...

Weyerhaeuser (WY) is back in focus after reporting second quarter 2026 earnings, with net income of US$162 million and earnings per share of US$0.23 from continuing operations, both higher than a year earlier. See our latest analysis for Weyerhaeuser. Despite a 1-day share price return that declined 1.5% to US$25.45, Weyerhaeuser has gained 8.3% over the past week and 9.3% over the past month, suggesting short term momentum has picked up even though the 1-year total shareholder return of 2.5%...

Marsh & McLennan Companies (MRSH) has created a US Semiconductor and AI Compute Practice and appointed Jessica Fields to lead it, putting fresh attention on how the stock reflects this technology focused insurance effort. See our latest analysis for Marsh & McLennan Companies. Marsh & McLennan Companies' recent focus on semiconductor and AI related insurance comes as the stock posts a 30 day share price return of 8.59% and a 90 day share price return of 18.40%. At the same time, the 1 year...

EPAM Systems stock is trading after a long stretch of weak returns, with the share price down about 84.5% over the past five years, while the company still screens as undervalued on several of Simply Wall St’s checks. Recent news on softer software services demand, alongside new work with OpenAI on applied AI solutions, gives investors fresh information to weigh against that valuation read. Over the last five years EPAM Systems has declined about 84.5%, which puts the current share price in...

Ternium (NYSE:TX) stock is in focus after Q2 2026 results showed higher sales, an increase in adjusted EBITDA margin to 16.5%, and an earnings surprise versus analyst expectations. See our latest analysis for Ternium. The Q2 earnings surprise and margin improvement appear to have reinforced interest in Ternium, with the share price at US$51.89 after a 21.38% 1 month share price return and a 75.22% 1 year total shareholder return, suggesting momentum has been building. If the recent move in...

Q2 2026 earnings focus for Crane stock Crane (CR) is in focus after reporting second quarter 2026 earnings, with sales of US$724.7 million and net income of US$95.9 million, alongside updated full year sales guidance and a confirmed quarterly dividend. See our latest analysis for Crane. Crane's share price has pulled back 2.0% over the past day, although it is still up 20.5% over the last 90 days and the 5 year total shareholder return is 241.1%. This suggests strong long term momentum...

Five Below (FIVE) is back in focus after a federal judge allowed investors to proceed with a certified class action over alleged misstatements on growth plans and inventory management, as well as ongoing consumer tariff refund lawsuits. See our latest analysis for Five Below. At a share price of $231.12, Five Below has seen a strong 30 day share price return of 31.13% and a 1 year total shareholder return of 74.15%. This suggests recent momentum as investors reassess both growth prospects and...

With the US unexpectedly losing 23,000 jobs in July and wage growth slowing while inflation sits at 3.5%, shoppers may start stretching every dollar. That shift in behavior can matter a lot for certain stocks that are tied to value focused spending. This article walks through three stocks from our Discount Retailers and Value Chains screener that appear particularly exposed to these labor market and inflation trends. The three stocks covered below are just a small sample, and the full screen...

CoreCivic’s share price has surged over the last few years, yet the stock currently screens as expensive on broad valuation checks, which leaves investors weighing strong recent returns against a low value score. CoreCivic has returned 213.0% over the past 3 years, which puts recent gains front and center for anyone assessing whether the current share price still offers value. New contracts and facility sales that strengthen the balance sheet and may support future cash generation now sit...

Tripadvisor (TRIP) drew investor attention on 6 August 2026 after reporting second quarter earnings that showed lower sales and net income compared with a year earlier, alongside a six month shift from profit to loss. See our latest analysis for Tripadvisor. The earnings miss was followed by a sharp market reaction, with Tripadvisor’s share price down 25.52% over the past day and 26.57% over the week, contributing to a year to date share price return of down 28.83% and a 1 year total...

In early August 2026, Kimberly-Clark reported past second-quarter results showing slightly higher sales of US$4,189 million but lower net income of US$345 million, while affirming a quarterly dividend of US$1.28 per share. The company also unveiled a patented alternative natural fiber platform using the hesperaloe plant, aiming to enhance product performance and sustainability while bolstering long-term fiber supply resilience. We’ll now examine how the earnings miss on revenue and the...

Cintas (NasdaqGS: CTAS) announced a leadership change, appointing Jim Rozakis as President while Todd Schneider continues as CEO. The company has formally separated the President and CEO roles, signaling a new executive structure for the business. Consider broadening your watchlist with other companies in similar industries through 78 resilient stocks with low risk scores NasdaqGS:CTAS 1-Year Stock Price Chart Cintas operates in the uniform rental and facility services space, an area that...

Collegium Pharmaceutical stock has delivered a 59.8% gain over the past five years, yet the recent share price pullback and a strong set of valuation checks suggest the market may be reassessing how cheap or expensive the current price really is. Over five years, Collegium Pharmaceutical has returned 59.8%, which points to meaningful value creation for longer term holders despite more recent weakness. Future growth in prescriptions and cash flow can support the current market value, while...

A federal court has just put a US$400 million White House ballroom project on ice, and that legal pause shines a harsh spotlight on companies that depend on Washington for big construction and real estate work. When projects stall, revenue visibility can blur fast. This article walks through three stocks exposed to this political drama, all on the wrong side of the news, so you can judge whether their risk profile still fits your portfolio. AECOM (ACM) Overview: AECOM is a Dallas...

Definium Therapeutics (DFTX) drew investor attention after reporting Q2 2026 results that showed a wider net loss and higher loss per share, along with recent Phase III data and financing updates related to its DT120 ODT program. See our latest analysis for Definium Therapeutics. The share price of Definium Therapeutics has reacted strongly to recent Phase III data and financing updates, with a 90 day share price return of 109.25% and a year to date share price return of 238.27%. The 1 year...

Rapport Therapeutics (RAPP) drew fresh investor attention after reporting second quarter 2026 results and outlining progress across its central nervous system pipeline, including new Phase 3 trials for lead candidate RAP-219. See our latest analysis for Rapport Therapeutics. The clinical updates appear to have coincided with a sharp re-rating in investor expectations, with Rapport Therapeutics posting a 1-day share price return of 9.21% and a year to date share price return of 64.89%. The...